Grifols, S.A (GRF) | Stock Overview & Key Data
Grifols, S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €34.31 on February 17, 2020
Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights
Key Statistics
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Grifols, S.A
GRF
|
6.09B Large-cap | -7.25% | 1.24% | -18.49% | -20.87% | -20.02% | 5.17% | -3.97% | -60.31% | -52.89% | 33.98% | 244.23% |
|
Laboratorios
ROVI
|
4.34B Large-cap | -4.70% | 3.25% | 11.63% | 25.93% | 28.02% | 58.55% | 101.84% | 68.26% | 449.09% | 1,459.62% | 743.04% |
|
Almirall S.A
ALM
|
2.76B Large-cap | -0.47% | 11.78% | -0.16% | 0.79% | -1.40% | 31.68% | 36.63% | -2.60% | -9.40% | 65.19% | -15.31% |
|
Pharma Mar S.A
PHM
|
1.68B Large-cap | -2.77% | 9.23% | 17.43% | 27.39% | 23.89% | 30.10% | 151.19% | -0.37% | 186.82% | 180.20% | 30.59% |
|
Faes Farma S.A
FAE
|
1.51B Large-cap | -2.24% | 6.90% | -6.07% | 6.90% | -8.05% | 15.38% | 50.00% | 38.33% | 75.18% | 77.12% | -48.94% |
|
Clinica Baviera S.A
CBAV
|
832.96M Mid-cap | -0.38% | 5.69% | 0.00% | 17.65% | 5.48% | 49.86% | 175.86% | 290.98% | 847.18% | 933.80% | 933.80% |
Ownership & Short Interest
Calculate Your Grifols, S.A Investment Returns
Long-Term Investment Performance Analysis
Grifols, S.A stock price in Jul 2016 was €20.25, A €1,000.00 lump sum investment in Grifols, S.A made 9 years ago would be worth approximately €441.98 today, representing a negative return of -55.80%. This translates to an annualized return (CAGR) of -8.02%.
9 Years 9 Months Investment Scenario (Jul 2016 - Apr 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is GRF's 52-week high and low?
- In the last 52 weeks, Grifols, S.A reached a high of €13.70 (on July 31, 2025) and a low of €8.01 (on May 12, 2025).
- What is the market cap and P/E ratio for GRF?
- Curious about Grifols, S.A's size and valuation? Its market capitalization stands at 6.09B. When it comes to valuation, the P/E ratio (trailing twelve months) is 15.58, and the forward P/E (looking ahead) is 7.76.
- Does GRF pay dividends? If so, what's the yield?
- Yes, Grifols, S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.39%, and the company has paid an average of €0.05 per share annually over the past 3 years.
- Who are Grifols, S.A's main competitors or similar companies to consider before investing?
When looking at Grifols, S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Laboratorios
ROVI4.34B Healthcare Drug Manufacturers - Specialty & Generic 58.55% 101.84% Almirall S.A
ALM2.76B Healthcare Drug Manufacturers - Specialty & Generic 31.68% 36.63% Pharma Mar S.A
PHM1.68B Healthcare Biotechnology 30.10% 151.19% Faes Farma S.A
FAE1.51B Healthcare Drug Manufacturers - Specialty & Generic 15.38% 50.00% Clinica Baviera S.A
CBAV832.96M Healthcare Diagnostics & Research 49.86% 175.86% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Grifols, S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Grifols, S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.17%, the Debt to Equity ratio from the most recent quarter is 126.83, and its Gross Profit Margin stands at 34.66%.
- What is the recent revenue and earnings growth for GRF?
- Looking at Grifols, S.A's growth, its revenue over the trailing twelve months (TTM) was €8B. Compared to the same quarter last year (YoY), quarterly revenue grew by 0.30%, and quarterly earnings saw a YoY growth of 42.30%.
- How much of GRF stock is held by insiders and institutions?
- Wondering who owns Grifols, S.A stock? Company insiders (like executives and directors) hold about 31.68% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 33.52%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.